The regulation will also apply to personal care shops such as spas and hair salons as well as city buildings.
And although the measure will not take effect until next month, companies must show an advisory notice on the claim by October 21. Persons with medical or religious exemption must provide a form declaring it. Persons who do not meet these requirements can use a company’s outdoor areas and are allowed to use toilets or pick up pick-up orders in the covered rooms.
The city will require patrons at large outdoor events with at least 5,000 attendees to show proof of vaccination or a negative Covid-19 test.
And on November 4, bars and similar places throughout the county must verify full vaccination of their guests and staff before entering their indoor areas.
The county — like many other parts of the United States — has registered a downward trend in new Covid-19 infections, hospitalizations and deaths, but officials warn that the best way to prevent numbers from ticking up again is to get vaccinated.
“As Halloween, Thanksgiving and the December holidays approach with rapid strides, we hope that with continued declines, we can plan gatherings, parties and perhaps travel to celebrate it with family and friends,” said Barbara Ferrer, director of public health. . for Los Angeles County, it said in a statement. “While we continue to live with the insecurities associated with a mutating virus, one thing is certain: regardless of your plans, they will be safer if you and your loved ones are vaccinated.”
According to data released Wednesday by the Centers for Disease Control and Prevention, more Americans are now getting booster shots in the United States than they are being vaccinated for the first time or being fully vaccinated.
8 states have less than 15% of ICU beds available
In other parts of the country, the fight against the virus still stretches hospital resources.
The dwindling capacity of Covid-19 has led many hospitals to be strained for resources and staff, often leaving them unable to provide the standard of care they would like, according to health professionals.
Whether the change is temporary or the beginning of the end is still not clear, health experts say, and now is not the time to become complacent.
“I’m worried we’re still having some tough days ahead,” said Dr. Ashish Jha, Dean of the Brown University School of Public Health. “Although we are doing reasonably well with vaccines, we need to do much better because the Delta variant is very good at finding people who are unvaccinated and infecting them.”
And with children under the age of 12 not yet eligible to be vaccinated, many experts are concerned about how children will fare.
While pediatric infections have declined, they remain high. Children under the age of 18 make up 22% of the U.S. population, but account for 27% of all cases nationwide, according to data released Monday by the American Academy of Pediatrics.
Child death is an ’embarrassment’
Child deaths due to a preventable disease, such as Covid-19, are the motivation for approving a vaccine for children, the U.S. Food and Drug Administration’s top vaccine official said Tuesday.
“In this latest wave of Covid-19, especially in the south, thousands of children have been hospitalized. And frankly, it’s an embarrassment in a developed country that even 100 children like us have died of infectious diseases that are can be prevented, “said Dr. Peter Marks, director of the Center for Biologics Evaluation and Research, in a town hall that hosted the Covid-19 Vaccine Education and Equity Project.
“We did not have a vaccine to give them, but I would hate to deprive children of their lives because we do not decide to vaccinate them, even at the relatively low risk,” Marks said.
According to the CDC, 645 children have died from Covid-19 in the United States.
“No parent should have to lose their child to a vaccine that can be prevented if we have a vaccine that can be inserted that is safe and effective. And we will only allow something to be approved that we find safe and effective,” marks said.
Marks said he did not know if the approval of a vaccine for children ages 5 to 11 would come after a meeting of the FDA’s Vaccines and Related Biological Products Advisory Committee scheduled for Oct. 14-15, but he said , that the FDA would quickly work through necessary data when they become available.
“Many of us who work at the FDA have young children, or they have grandchildren. And that’s clearly one of the most important issues that needs to be addressed, so we are not going to waste time,” he said.
Johnson & Johnson is requesting permission for the booster dose
As officials prepare to review vaccines for young children, they are also considering approving a booster dose to increase protection for people who received the one-shot Johnson & Johnson vaccine.
J&J said Tuesday that it has asked the FDA to approve booster shots for its vaccine. According to the CDC, about 15 million people in the United States have received a J&J shot.
The company said it has made the request, but leaves the decisions about who should get the boosters and when up to the FDA and CDC.
The FDA’s advisory committee on vaccines and related biological products is scheduled to meet Oct. 14 and 15 to consider requests from Moderna and Johnson & Johnson to add booster doses to their Covid-19 vaccines.
Last month, the company released some data from three different studies that showed boosting the vaccine after two months or six months of increased immune protection.
“We announced that six months of data is a very strong, very strong boost, just like an amazingly strong boost,” said Dr. Mathai Mammen, head of global research and development for J & J’s vaccine arm, Janssen. “And that two months is a good boost, and that two-month good boost was associated with 94% vaccine efficacy, across the board, at all ages.”
CNN’s Virginia Langmaid, Maggie Fox, Christina Maxouris, Jen Christensen, Holly Yan, Susannah Cullinane, Ben Tinker, Jacqueline Howard, Mallory Simon and Theresa Waldrop contributed to this report.